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Cone versus rod disease in a mutant Rpgr mouse caused by
different genetic backgrounds
Abstract
PURPOSE. To establish mouse models for RPGR-associated diseases by generating and characterizing
an Rpgr mutation (inframe deletion of exon 4) in two different genetic backgrounds(BL/6 and BALB/c).
METHODS. Gene targeting in embryonic stem (ES) cells was performed to introduce a in-frame
deletion of exon 4 in the Rpgr gene (RpgrEx4). Subsequently, the mutation was introduced in two
different inbred mouse strains by successive breeding. Mutant and wild-type mice of both strains were
characterized by electroretinography (ERG) and histology at five time points (1, 3, 6, 9, and 12 months).
RPGR transcript amounts were assessed by quantitative RT-PCR. A variety of photoreceptor proteins,
including RPGR-ORF15, RPGRIP, PDE6/PrBP, rhodopsin, and cone opsin, were localized on retinal
sections by immunohistochemistry. RESULTS. Mislocalization of rhodopsin and cone opsin was an
early pathologic event in mutant mice of both lines. In contrast, RPGR-ORF15 as well as RPGRIP1 and
PDE6/PrBP showed similar localizations in mutant and wild-type animals. Functional and histologic
studies revealed a mild rod-dominated phenotype in mutant male mice on the BL/6 background,
whereas a cone-dominated phenotype was observed for the same mutation in the BALB/c background.
CONCLUSIONS. Both Rpgr mutant mouse lines developed retinal disease with a striking effect of the
genetic background. Conespecific modifiers might influence the retinal phenotype in the BALB/c strain.
The two lines provide models to study RPGR function in rods and cones, respectively. (Invest
Ophthalmol Vis Sci. 2010;51:1106-1115) DOI:10.1167/iovs.08-2742
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PURPOSE. To establish mouse models for RPGR-associated dis-
eases by generating and characterizing an Rpgr mutation (in-
frame deletion of exon 4) in two different genetic backgrounds
(BL/6 and BALB/c).
METHODS. Gene targeting in embryonic stem (ES) cells was
performed to introduce a in-frame deletion of exon 4 in the
Rpgr gene (RpgrEx4). Subsequently, the mutation was intro-
duced in two different inbred mouse strains by successive
breeding. Mutant and wild-type mice of both strains were
characterized by electroretinography (ERG) and histology at
five time points (1, 3, 6, 9, and 12 months). RPGR transcript
amounts were assessed by quantitative RT-PCR. A variety of
photoreceptor proteins, including RPGR-ORF15, RPGRIP,
PDE6/PrBP, rhodopsin, and cone opsin, were localized on
retinal sections by immunohistochemistry.
RESULTS. Mislocalization of rhodopsin and cone opsin was an
early pathologic event in mutant mice of both lines. In con-
trast, RPGR-ORF15 as well as RPGRIP1 and PDE6/PrBP
showed similar localizations in mutant and wild-type animals.
Functional and histologic studies revealed a mild rod-domi-
nated phenotype in mutant male mice on the BL/6 back-
ground, whereas a cone-dominated phenotype was observed
for the same mutation in the BALB/c background.
CONCLUSIONS. Both Rpgr mutant mouse lines developed retinal
disease with a striking effect of the genetic background. Cone-
specific modifiers might influence the retinal phenotype in the
BALB/c strain. The two lines provide models to study RPGR
function in rods and cones, respectively. (Invest Ophthalmol
Vis Sci. 2010;51:1106–1115) DOI:10.1167/iovs.08-2742
Degeneration of initially rod and later of cone photorecep-tor cells is a common hallmark of the clinical and genetic
heterogeneous disease retinitis pigmentosa (RP). The X-linked
form of RP (XlRP) is the most severe form in terms of onset and
progression; males are predominantly affected though occa-
sionally carrier females may show variable expressivity of dis-
ease manifestations.1,2 Mutations in the retinitis pigmentosa
GTPase regulator gene (RPGR) are the major cause and ac-
count for approximately 70% of all XlRP cases.3 The second
major X-linked gene was also identified and was designated
RP2.4 Expression of RPGR transcript isoforms were detected
in many tissues, including retina, brain, lung, kidney, and testis,
of several species.5 In humans as well as in mice, RPGR was
described to consist of 19 constitutively expressed exons
(RPGR1–19 variant).
6,7 Exon 19 contains a conserved isopreny-
lation motif, indicating that this isoform might be posttransla-
tionally modified.8 Several studies reported a high degree of
alternative splicing, and many novel exons—some of them
tissue specific—were discovered. The retina-abundant RPGR-
ORF15 isoform has an alternative C terminus that is rich in
acidic amino acids.3 Another novel isoform, RPGR-9a, is pre-
dominantly expressed in cone photoreceptors of the human
retina.9 A common feature of most protein isoforms is the
N-terminal regulator of chromosome condensation 1 (RCC1)-
like domain (RLD),6,7 encoded by exons 2 to 10. RCC1 is a
guanine nucleotide exchange factor (GEF) for small GTPase
Ran and is involved in nuclear export and import path-
ways.10,11 However, GEF activity has never been demonstrated
for RPGR. The RLD has also been shown to interact with
several proteins: RPGR-interacting protein 1 (RPGRIP1), struc-
tural maintenance of chromosomes (SMC) 1 and 3 proteins,
and prenyl-binding protein  (PrBP), formerly known as phos-
phodiesterase delta subunit (PDE6).12–14 In addition, several
ciliary/basal body and intraflagellar transport (IFT) proteins
were found to interact with the C terminus of the RPGR1–19
and with the RPGR-ORF15 isoforms.15–18 Accordingly, these
isoforms localize mainly in cilia and basal bodies, suggesting a
ciliary function.19,20
RPGR mutations in the RLD and exon ORF15 account for
approximately 32% and 56% of XlRP cases, respectively (http://
rpgr.hgu.mrc.ac.uk). These pathogenic changes can lead to
either classic RP or to cone-rod dystrophy, cone dystrophy, and
macular degeneration, indicating that RPGR is also essential for
cone function.21–23 The phenotypic variability resulting from
mutations in RPGR was expanded by patients displaying RP,
recurrent sinorespiratory infections, and hearing loss.24,25 In
addition, mutations were associated with RP in conjunction
with primary ciliary dyskinesia.26 To date, no genotype-pheno-
type correlation could be assigned. Two recent studies re-
ported families carrying the same RPGR mutation but exhibit-
ing discordant phenotypes.27 These cases indicate the
involvement of modifier genes. Knowledge about the exact
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influence of such modifying factors is limited. In addition, no
animal model of retinal degeneration exists that displays a
similar shift in the phenotype between rod and cone photore-
ceptors.
We generated a transgenic mouse model with an in-frame
deletion of exon 4 of Rpgr. This alteration mimics mutations in
patients with RP that lead to exon 4 skipping.28,29 In addition,
we bred the mutation in two different mouse strains (BL/6 and
BALB/c). This study describes the detailed characterization of
the retinal phenotypes in the two genetic backgrounds. We
found both mouse strains developing retinal disease but strik-
ingly either rod or cone dominated. To the best of our knowl-
edge, this is the first example of different photoreceptor-spe-
cific (i.e., rods vs. cones) phenotypes in two different mouse
strains carrying the same Rpgr mutation.
MATERIALS AND METHODS
Animals
All experiments were performed in compliance with the National
Institutes of Health guidelines, as approved by the Swiss cantonal
veterinary office, and the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research. Animals were born and maintained
in controlled ambient illumination on a 12-hour light/12-hour dark
cycle with an illumination of 60 lux. For breeding, male wild-type BL/6
animals were purchased from the Jackson Laboratory (Bar Harbor, ME).
Male wild-type BALB/c animals were obtained from the Bundesinstitut
fu¨r Risikobewertung (Berlin, Germany).
Generation of RpgrEx4 Mice
For construction of the RpgrEx4 targeting vector, a genomic region of
0.8 kb (intron 2_F 5 GCTCTAGACCCAAAGAAGGTGATGGTCTACCA
3 to intron 3_R 5 CCGCTCGAGTCATGGATCTCACAGTCTGCAG 3)
of the murine Rpgr gene was amplified from the 129 mouse strain and
cloned into the 5 multiple cloning site of the neomycin casette of the
pTG1-vector (Transgenics, Berlin, Germany). Subsequently, a second
genomic region of 5.5 kb of the 129 Rpgr gene (intron 4_F 5
ACGCGTCGACGTGTTTTGTGGAAGCCATAGG 3 to intron 6_R 5
AGCCGTCGACTCACTCTTGTAGCATGCCTTGA 3) was cloned 3 of
the neomycin cassette. The correct insertion direction of the fragments
was confirmed by sequencing. The vector was linearized with NotI and
transfected into a male embryonic stem (ES) cell line of the 129 mouse
strain, as described elsewhere.30 Identification of ES clones carrying
the recombinant Rpgr allel was made by Southern blot analysis using a
5 probe positioned outside the targeting construct (exon 2_F 5
GCTCTAGACAGGTGCTGTGTTTACGTTTGG 3 to intron 2_R 5 CG-
TATCTTTCTGTGTTGAAGCAC 3). The injection of mutant ES cells
into BL/6 blastocysts was performed according to standard methods.
Two recombinant ES cell lines (C2 and F10) produced chimeric off-
spring with germline transmission. These were used for establishing
two independent mutant mouse lines by crossing to wild-type BL/6
mice for at least eight generations. In addition, the mutation was
crossed into the albino BALB/c mouse strain for at least seven gener-
ations. In generation F8, male and female mice heterozygous for the
Rpe65 polymorphism (p.M450L) were crossed to obtain homozygous
leucine and methionine offspring.
Genotyping of Rpgr and Rpe65
Genotyping was performed by PCR on DNA isolated from tail biopsies.
For Rpgr, two different forward primers were used to amplify a
wild-type specific (exon 4, 5 GTGAAACTTGCTGCCTGTGGA 3) and
a mutant specific product (neomycin cassette, 5 AGCACGTACTCG-
GATGGAAG 3), respectively. A third common reverse primer is lo-
cated in intron 4 (5 agcagtcatctccgttttaatc 3). The polymorphism in
Rpe65 was genotyped by sequencing using flanking primers (Rpe65_F
5 TGACAAGGTAATAAAGCATC 3 and Rpe65_R 5 ATTACCAT-
CATCTTCTTCCA 3).
Morphometric Analysis on Plastic Sections
Mice were anesthetized with CO2 and subsequently killed by cervical
dislocation. Eyes were marked at the superior pole, removed, and fixed
in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3) at 4°C
overnight. Eyes were bisectioned at the optic nerve head into a supe-
rior and an inferior part, washed in cacodylate buffer, poststained in
osmium tetroxide for 1 hour, dehydrated, and embedded in resin
(Epon 812; Sigma-Aldrich, Buchs, Switzerland). Tissue sections of 0.5
m were stained with toluidine blue and analyzed under a microscope
(Carl Zeiss AG, Feldbach, Switzerland).
For morphometric analysis of wild-type and mutant mice of both
strains, sections from the inferior central retina containing the optic
nerve head and the ora serrata on both sides were chosen for retinal
measurements. For each eye, three sections were examined. Four areas
were chosen from each section (periphery temporal, center temporal,
center nasal, and periphery nasal). The central areas were defined as
located 15° temporally and nasally from the optic nerve head (0°), and
the temporal region was chosen 30° from the ora serrata of each side.
Measurements of the thickness of the outer nuclear layer (ONL) and
the length of the rod inner segment (RIS) and rod outer segment (ROS)
were performed, each in triplicate. Additionally, the number of nuclei
in the ONL was counted in an area of 1000 m2 (20  50 m). The
mean value of ROS, RIS, and ONL thickness and mean number of nuclei
in the ONL for each area was calculated (2  n  5 per genotype). For
quantification of cones, cone nuclei were counted in the whole area of
one picture taken at 40 magnification. Statistical analysis was per-
formed using the 95% confidence interval (CI) or Student’s t-test.
Electroretinography
ERG methodology has been described previously.31 Mice were dark
adapted (2 hours), pupils were dilated by tropicamide 0.5% and
atropine 1%, and mice were anesthetized by injection of xylazine (15
mg/kg body weight) and ketamine (100 mg/kg). The recording elec-
trode was a monopolar contact lens electrode, and a subcutaneous
fixed silver needle was the reference and ground electrode. For re-
cording, the mouse was placed into a commercially available Ganzfeld
bowl (Toennies Multiliner Vision, Ho¨chberg, Germany), with the ex-
amined eye facing the back of the globe. The signal was amplified by
10,000 with a bandpass filter from 1 to 300 Hz. Oscillatory potentials
were obtained by bandpass filtering from 100 to 300 Hz.
In the dark-adapted state, a flash series consisting of 8 steps started
at –4.0 log cd  s/m2 and reached 0.48 log cd  s/m2. For a-wave
recording, six additional flash energies were applied ranging from 1.0
to 2.5 log cd  s/m2. These high-intensity stimuli were provided by a
photoflash mounted in the Ganzfeld globe. After recording the a-wave,
the background light (1.5 log cd  m2) was turned on, and the
photopic ERG was recorded (1.2, 1.4 log cd  s/m2; average of 10
recordings at 1.5 Hz). Subsequently, the animals were further light
adapted for 10 minutes, and the photopic ERG was recorded again
using a series of flash energies (0.3, 0.7, 1.2, 1.4, 1.7, and 2.0 log cd 
s/m2). The b-wave amplitude was determined from a-wave trough to
b-wave peak, behind the last prominent oscillatory potential. For the
determination of b-wave amplitudes and implicit times, the third os-
cillatory potential was chosen because of low variability. Statistical
analysis was performed using ANOVA for repeated measurements, if
applicable. Single recordings were tested by the two-tailed t-test. The
critical P value was set to 0.05.
Generation Isoform-Specific RPGR Antibody
An epitope within the hRPGR-ORF15 protein (1100HKTYQKKSVT-
NTQGNGKE1117) (National Center for Biotechnology Information ac-
cession nos. NP_000319 and NP_ 001030025) was chosen to generate
the isoform-specific antibody AbC2.1 (Eurogentec, Seraing, Belgium).
The antiserum was affinity-purified against the cognate peptide accord-
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ing to manufacturer’s instructions (Sulfolink; Pierce Biotechnology,
Rockford, IL). Briefly, the antiserum was incubated on a column with
covalently bound peptide for 1 hour at room temperature to allow
binding to occur. After rinsing with PBS, the antibody bound to the
column was eluted from the column by pH-shift. IgG concentration of
affinity-purified antibodies was determined using a fluorospectrometer
(NanoDrop ND-3300; Witec AG, Littau, Switzerland).
Quantitative Real-Time PCR of Rpgr Transcript
To study the expression of Rpgr in wild-type and mutant animals of the
RpgrEx4 strains, a quantitative real-time PCR assay was performed.
Retinal RNA was extracted from BL/6 (n  5 for each wild-type and
mutant) and BALB/c (n  2 wild-type; n  3 mutant) animals, and
cDNA was generated and analyzed from each animal. A gene expres-
sion assay (TaqMan; ABI, Rotkreuz, Switzerland) was ordered in which
the probe covered the exon 8/9 boundary (assay ID Mm00488059_m1;
ABI). Sequencing of the amplified product from the assay showed
mouse RPGR sequences specific for exons 8 and 9. Expression levels
were determined and pooled from five technical replicates, with am-
plification curves starting between 25 and 28 cycles (ABI HT 7900;
TaqMan). Data were analyzed using the SDS 2.2 software (ABI). Ex-
pression levels were normalized to 18S ribosomal RNA as endogenous
control. Error bars represent 95% CIs.
Immunohistochemistry
Animals were anesthetized by inhalation of CO2 or by injection of
ketamine-xylazine and subsequently were killed by cervical disloca-
tion. Eyes were removed and either directly embedded in optimal
cutting temperature compound (Tissue Tek; Digitana, Horgen, Swit-
zerland) or fixed in 4% paraformaldehyde in PBS and subsequently
cryoprotected by treatment with sucrose in ascending concentrations
(10% wt/vol, 20% wt/vol, and 30% wt/vol in PBS) at 4°C. Sections of 8
to 10 m were cut on a cryostat and air-dried (CM3050S; Leica Micro-
systems, Glattbrugg, Switzerland). After blocking with 10% normal
goat serum (NGS) sections were incubated overnight with primary
antibody, washed with PBS, and treated with Cy3-labeled anti-rabbit
(1:500), Cy3-labeled anti-mouse (1:500), or Alexa488-labeld anti-mouse
(1:500) antibody (Dianova, Hamburg, Germany). Primary antibodies
against both rhodopsin (1:10.000, RetP1; Sigma, St. Louis, MO) and
cone opsin (1:4000, MWL cone opsin, kindly provided by Christian
Grimm, University Hospital Zurich, Switzerland) were applied to fixed
eyes of wild-type and mutant animals of the RpgrEx4 BL/6 (n 
4/genotype) and BALB/c (n  2/genotype) strain. An anti-PrBP anti-
body (kindly provided by Rick Cote, University of New Hampshire,
Durham, NH) was used on fixed sections (n  2/genotype) in a 1:200
dilution. For detection of proteins in the connecting cilium, unfixed
eyes were used as other conditions were found to quench the signal.
RPGR AbC2 was used in a 1:25 and RPGRIP Ab3812 (kindly provided by
Ronald Roepman, Nijmegen, Netherlands) in a 1:200 dilution (n 
2/genotype). As markers for the connecting cilium and the centro-
some/basal body, acetylated -tubulin (Sigma) and -tubulin (Abcam,
Cambridge, UK) were used (n 2/genotype), respectively. Slides were
photographed with a Zeiss microscope equipped with ApoTome tech-
nology. For each antibody comparable acquisition times for wild-type
and mutant retinas were used. Images were processed with graphics
editing software (PhotoShop; Adobe, Munich, Germany) by applying
the same parameters for each one.
RESULTS
Generation of Rpgr Mutant Mice in Two Different
Genetic Backgrounds
We used gene-targeting technology to generate a mouse line
with a deletion mutation in the Rpgr gene. In the gene-target-
ing construct, exon 4 was replaced by a neomycin cassette,
leading to an in-frame deletion of 63 bp of the Rpgr transcript
and 21 amino acids of the RPGR protein (Fig. 1A). The mutant
mouse line was obtained after injection of two independently
targeted ES clones (C2 and F10). The C2 and F10 ES clones
were selected after testing for correctly targeted Rpgr gene
copies (Fig. 1B). From both ES cell lines we obtained chimeric
animals. Germline transmission was confirmed for both and
resulted in viable and fertile hemizygous male mice.
FIGURE 1. Generation of Rpgr mu-
tant mouse lines. (A) Scheme of wild-
type allele and targeting construct of
the Rpgr gene and the four known
interaction partners of the RCC1-like
domain (RLD). Exon 4, which is lo-
cated within the RLD, was replaced
by a neomycin cassette (Neo) in the
construct. This leads to a lack of
exon 4 in the transcript of the tar-
geted allele (RpgrEx4). Direction of
transcription of neomycin is the
same as for Rpgr. (B). Digestion with
BamHI and subsequent Southern
blot analysis with a probe depicted in
(A) resulted in a fragment of 7.8 kb
for wild-type () and a truncated
fragment (6.5 kb) for mutant ()
Rpgr. This ES clone (C2) and a sec-
ond one (F10) were chosen for fur-
ther injection into blastocysts. (C)
RT-PCR on mouse retinal cDNA using
forward and reverse primers in ex-
ons 2 and 5 (as indicated in A). In the
mutant animals only transcripts skip-
ping exon 4, and thus showing 63-bp
deletions, were found. In wild-type
animals only correctly the spliced
product was detected. (D) Quantita-
tive RT-PCR of RpgrEx4 BL/6 and
RpgrEx4 BALB/c wild-type and mutant mouse retinal cDNA. Expression levels of Rpgr (indicated in relative units) were not significantly different
between wild-type and mutant animals in both strains. Error bars represent 95% CI.
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The mutation was first bred into the pigmented BL/6 strain
(C2 and F10 line) for at least eight generations. Several studies
reported on modifier genes influencing retinal degeneration
and light damage susceptibility in BALB/c mice.32,33 Thus, we
decided to breed the RpgrEx4 mutation into the albino BALB/c
strain (C2 line) for another seven to eight generations.
Expression of Wild-type and Mutant Rpgr
Deletion of exon 4 in the mutant mice was verified by conven-
tional RT-PCR using forward and reverse primers in exons 2
and 5, respectively. In wild-type mice of both backgrounds, the
expected band of 430 bp was found (Fig. 1C). Mutant animals
specifically showed a lower band corresponding to the dele-
tion of 63 bp of exon 4. The bands were verified by sequenc-
ing. The deletion of exon 4 does not alter the reading frame but
would lead to a lack of 21 amino acids in the predicted RLD
(Fig. 1A). Expression levels of wild-type and mutant Rpgr
transcripts were analyzed by quantitative RT-PCR on mouse
retinal cDNA (Fig. 1D). The probe (TaqMan; ABI) detected the
exon 8/9 boundary downstream of the genomic neomycin
cassette insertion site. Comparable expression levels of wild-
type and mutant transcripts were found in both strains, indi-
cating that the deletion of exon 4 does not influence RPGR
transcript levels. These results suggest that Rpgr is equally
expressed in wild-type and mutant animals.
Assessment of Retinal Function by
Electroretinography
For assessment of functional consequences of the RpgrEx4
mutation in the two mouse lines, mutant male mice and their
littermates were subjected to ERG measurements.
The RpgrEx4 BL/6 line displayed a slightly progressive loss
of amplitude of the scotopic a-wave from the age of 3 months
onward (Fig. 2). The scotopic b-wave remained unaffected at
all ages examined, whereas the photopic b-wave was margin-
ally reduced but only at 9 months of age. Surprisingly, func-
tional measurements revealed a strikingly different result in the
RpgrEx4 BALB/c background (Fig. 3). Here, the cone system
was affected already at 1 month of age, as indicated by the
reduction of the photopic b-wave in mutant animals (Fig. 3C).
Simultaneously, the amplitudes of the scotopic a-wave were
reduced. At 3 months, the RpgrEx4 BALB/c line showed a
cone-rod phenotype compared with the isolated mild rod phe-
notype in RpgrEx4 BL/6 mice at a comparable age (Figs. 2B,
3B). Over time, the decrease in the rod photoreceptor re-
sponse in RpgrEx4 BALB/c mice was progressive, whereas the
scotopic b-wave was not affected at any time point examined.
Given that the reduction of the a-wave was mild in both strains,
this effect might not have been observed in the b-wave re-
sponses because this effect could have been masked by sum-
FIGURE 2. ERG measurements of RpgrEx4 BL/6. (A) ERG data from mutant animals (gray line) and their control littermates (black line) recorded
in animals of 1, 3, 6, 9, and 12 months of age. Amplitudes (V) from the scotopic a-wave (a), the scotopic b-wave (b), and the photopic b-wave
(c) are plotted against the flash intensity ([mcd  s/m2] for a and b, and [cd  s/m2] for c). In the RpgrEx4 BL/6 line, a mild progressive reduction
of the scotopic a-wave was present in mutant animals starting at 3 months of age. The photopic b-wave was only marginally reduced in animals
at 9 months of age. (B) Mean curve of scotopic ERG recorded at flash intensity of 3000 mcd  s/m2 and photopic ERG recorded at 25 cd  s/m2 in
mice at 3 months of age (wt, n  10; mut, n  7). Mutant mice show a mild reduction of the scotopic a-wave, but the photopic response was
not affected. Error bars represent SD. Statistical analysis was conducted with ANOVA (*P  0.05). Single P-values are indicated.
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mation effects during transmission. It is important to empha-
size the stable photopic b-wave in wild-type animals until 12
months of age (Fig. 3C) though the wild-type scotopic re-
sponses significantly declined during aging. This age-related
retinal degeneration is well known to occur in BALB/c and, to
a lesser extent, in BL/6 mice.34
Retinal Morphology
To determine morphologic changes accompanying the retinal
dysfunction indicated by ERG examinations, the same five time
points of ERG measurements were chosen for histologic anal-
yses of the retina (1, 3, 6, 9, and 12 months). In both lines,
retinal morphology was properly organized in mice at the age
of 1 month, indicating normal retinal development (Figs. 4A,
B). In both lines (RpgrEx4 BL/6 and RpgrEx4 BALB/c), no
obvious differences in retinal architecture were identified be-
tween wild-type and mutant animals. The age-related retinal
degeneration naturally occurring in BALB/c mice was again
evident from 6 months onward.
For the detection of subtle changes within the retina that
might reflect the reduction in the rod and cone responses in
the ERG, a detailed morphometric analysis was performed. In
RpgrEx4 BL/6 animals, a tendency toward reduction of the thick-
ness of the outer nuclear layer (ONL), outer segments (OS), and
inner segments (IS) was found in mice aged 6 months or older
(Supplementary Fig. S1; all Supplementary Figures are available at
http://www.iovs.org/cgi/content/full/51/2/1106/DC1). Overall,
these subtle changes in retinal morphology fit well with the
observedmild decrease in the photoreceptor response on ERG. In
the RpgrEx4 BALB/c line, no differences between wild-type and
mutant mice were apparent up to 3 months (Supplementary Fig.
S2). We cannot exclude mutation-specific effects at later stages,
which might be masked by the age-related retinal degeneration.
The defect in the cone system in RpgrEx4 BALB/c identified
by ERG prompted us to test whether this defect is caused by
the loss of cone photoreceptor cells. Analysis of the histologic
sections of the BALB/c strain (Fig. 4B) suggested that in older
animals (9 and 12 months) the number of cones might be
reduced (data not shown). Cone numbers of wild-type animals
of 1 month and 12 months were similar, indicating that cones
are not prone to age-related degeneration as are rods (Fig. 4B;
Supplementary Fig. S2). These observations are consistent with
the cone dysfunction identified in ERG measurements and
might further emphasize the effect of the RpgrEx4 mutation
on cones in BALB/c mice.
Localization of RPGR-ORF15, Interacting Proteins,
and Ciliary Markers
We next investigated the localization of wild-type and mutant
protein in the retina. A set of antibodies against RPGR, its
interaction partners, and ciliary and other photoreceptor-spe-
FIGURE 3. ERG measurements of RpgrEx4 BALB/c mice. (A) RpgrEx4 BALB/c ERG data recorded equivalently as the RpgrEx4 BL/6 data. Here,
a decline of the photopic b-wave and the scotopic a-wave was already evident at the age of 1 month. The decline of the photopic b-wave was
progressive over time. The scotopic a-wave was diminished in both wild-type and mutant animals from 6 month onward during the aging process.
(B) The mean RpgrEx4 BALB/c ERG curves recorded under the same scotopic and photopic conditions, such as in RpgrEx4 BL/6, revealed that
scotopic responses were mildly reduced, whereas photopic responses were severely diminished at 3 months of age (wt, n  5; mut, n  7). Error
bars represent SD. Statistical analysis was conducted with ANOVA (*P  0.05). Single P-values are indicated.
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cific proteins was applied on retinal sections. The RPGR anti-
body was directed against the ORF15 isoform (AbC2.1) and
produced strong and specific signals. Specificity was shown by
blocking with the cognate peptide (Supplementary Fig. S3). An
intense punctate staining pattern was observed in the area of
the connecting cilium with AbC2.1 (Figs. 5A–D). This localiza-
tion of RPGR-ORF15 has been described in mouse using a
different set of antibodies.35 Comparison of the staining be-
tween wild-type and mutant revealed the same pattern. Thus,
the mutation had no influence on localization of the protein.
The staining pattern observed with this antibody closely resem-
bled -tubulin, a marker for the basal body, indicating that the
ORF15 isoform specifically localizes there (Figs. 5I–J). Addi-
tionally, we investigated the localization of RPGRIP1. As ex-
pected, RPGRIP1 was found along the ciliary axoneme in
wild-type and mutant retinas, similar to acetylated -tubulin
(Figs. 5E–H, M–P). An antibody against PDE6/PrBP, which
was the first known interaction partner of RPGR, stained the
inner segments of rods and cones in both mouse lines, as
described by others36 (Supplementary Fig. S4). The integrity of
the ciliary structures and components was not disturbed in
mutant photoreceptors, as suggested by staining with the cili-
ary markers -tubulin and acetylated -tubulin. Thus, mislocal-
ization of RPGR or gross disarrangement of connecting cilia is
not the cause of retinal dysfunction and degeneration in these
two mouse lines.
Mislocalization of Visual Pigments in Rpgr
Mutant Mice
Several mouse models with defects in known or putative pro-
teins of ciliary transport pathways show aberrant localization
of components of the phototransduction cascade, such as
rhodopsin, cone opsin, arrestin, and transducin.37–40 For
RPGR, several lines of evidence exist that it also might be
involved in ciliary transport. In addition, in a knockout mouse
model for Rpgr and in a canine XlPRA2 model, alterations in
the localization of visual pigments were described.41,42 We
stained retinas with antibodies against rhodopsin and cone
opsin and analyzed mice at 1 month of age to elucidate primary
defects before or simultaneous with the occurrence of func-
tional impairments. These experiments revealed mislocaliza-
tion of cone opsin in both mutant mouse strains (Figs. 6B, D).
In addition to the localization in cone outer segments (COS), it
was found in the outer nuclear layer and the cone synapses
(Figs. 6B, D, arrow). Similarly, rhodopsin was partially mislo-
calized in the perinuclear region of rod photoreceptor cells
from mutant male mice of both lines (RpgrEx4 BL/6 and
RpgrEx4 BALB/c; Figs. 6F, H). To test whether other proteins
might be affected by a localization defect, we additionally
stained dark-adapted retinas for arrestin and transducin. These
proteins were shown to localize in the IS and OS in the dark,
respectively.43 In contrast to cone opsin and rhodopsin, these
proteins showed no aberrant localization in mutant mice (Sup-
plementary Fig. S5).
Evaluation of Rpe65 as Modifier Gene
Based on the different phenotypes occurring in BL/6 and
BALB/c mice, both carrying the same RpgrEx4 mutation, we
assumed that a strain-specific modifier must exist. To test
whether the RPE65 polymorphism at position 450 of the amino
acid sequence has an effect on the phenotype in the BALB/c
line, we designed a breeding scheme to obtain BALB/c mice
carrying the BL/6 (methionine) variant at position 450. Wild-
type and mutant male mice at the age of 5 to 6 weeks under-
went phenotype analysis by ERG. We still observed a cone-rod
phenotype in mutant animals carrying the BL/6 variant (methi-
onine) of RPE65 in an otherwise highly homogenous BALB/c
background (0.5% BL/6 after 8 generations; data not shown).
Therefore, RPE65 alone is not responsible for this modifying
effect.
FIGURE 4. Histologic analysis of
RpgrEx4 BL/6 and RpgrEx4 BALB/c
retinas. (A) Morphology was exam-
ined in semithin plastic sections at 1,
3, 6, 9, and 12 months. In RpgrEx4
BL/6, no obvious differences be-
tween wild-type and mutant animals
were detected. (B) Histologic sec-
tions of RpgrEx4 BALB/c animals
showed similar morphology in wild-
type and mutant animals. In aging
BALB/c mice 6 months and older,
naturally occurring retinal degenera-
tion was found in both genotypes.
Scale bar, 50 m. Error bars repre-
sent SD.
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DISCUSSION
In this study we showed that two mouse strains carrying the
same RpgrEx4 mutation display strain-independent but also
strain-specific characteristics of disease manifestations. Our
findings indicate an important role of the genetic background
on the degeneration of rod and cone photoreceptor cells as
well as RPGR function. Moreover, the BALB/c line provides the
first model for cone-rod degeneration because of an Rpgr
mutation in mice.
Influence of the Genetic Background on the
Disease Phenotype
The most striking finding of our study was the manifestation of
different phenotypes in the two mouse lines carrying the same
FIGURE 6. Localization of rhodopsin and MWL cone opsin. Immunohistochemistry on frozen sections
of wild-type and mutant mice of the BL/6 (n  4 per genotype) and BALB/c (n  2 per genotype)
backgrounds at the age of 1 month. (A–D) Stainings with an antibody against cone opsin revealed
mislocalization in the perinuclear region and the cone pedicles (arrows). This defect was detected in
3 of 4 RpgrEx4 BL/6 and in all RpgrEx4 BALB/c mutant mice. (E–H) Rhodopsin staining identified a
localization defect in mutant animals of both genetic backgrounds. Fluorescent signals were found not
only in the outer segments but also in the perinuclear region of photoreceptor nuclei (arrows). Scale
bar, 50 m.
FIGURE 5. Localization of different
ciliary proteins. (A–D) The RPGR-
ORF15 isoform was localized with the
AbC2.1 in frozen sections in wild-type
and mutant animals (n  2 per geno-
type) of both backgrounds at 6 months
of age. A speckled fluorescent pattern
reminiscent of basal body localization
was observed (see -tubulin as a
marker for basal bodies; I–L). No obvi-
ous differences between the geno-
types or the strains were found. (E, F)
Localization of RPGRIP revealed stain-
ing of the ciliary axoneme (see acet.
-tubulin as a marker of the ciliary ax-
oneme; M–P). Again, the same pattern
was found in wild-type and mutant an-
imals of the RpgrEx4 BL/6 and
RpgrEx4 BALB/c lines. (I–L) The basal
body marker -tubulin confirmed the
staining pattern of RPGR-ORF15.
(M–P) Similarly, acetylated (acet.) -tu-
bulin, a marker for the ciliary axon-
eme, revealed staining similar to that of
RPGRIP. The two markers of the basal
body and the axoneme suggested that
the cilium in the mutants in both back-
grounds was preserved. Of note, stain-
ings of RPGR, RPGRIP, and the ciliary
markers were performed in consecu-
tive sections. Scale bar, 50 m.
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Rpgr mutation. We observed that RpgrEx4 BL/6 mice pre-
sented with a mild rod phenotype, whereas the RpgrEx4
BALB/c strain developed an early-onset cone-rod phenotype.
This result indicates that genetic modifiers act on the physio-
logical homeostasis of rod and especially cone photoreceptors
in addition to the RpgrEx4 mutation. Variability in clinical
manifestations was found in carrier females with the same
mutation in exon 8 and in dizygotic twins with an RPGR-ORF15
mutation.27,44 One sibling had RP, and the other had a cone-
rod dystrophy. This situation is reminiscent of the phenotypic
variability of our RpgrEx4 mutant mice. To date, the effect of
the genetic background has only been described to alter onset,
severity, and progression of retinal degeneration.45 To the best
of our knowledge, we describe for the first time an impact of
the genetic background on the primarily affected photorecep-
tor cell type (i.e., rods vs. cones) because it was also observed
in human patients. One previously identified modifier gene for
retinal degeneration in mice is Rpe65. The variant with a
leucine at position 450 of this protein renders BALB/c mice
more susceptible to light-induced retinal degeneration by alter-
ing rhodopsin regeneration kinetics compared with mice car-
rying methionine at this position (e.g., BL/6).46 Introducing the
methionine at position 450 into the BALB/c background al-
lowed us to elucidate the influence of this polymorphism on
the phenotype of RpgrEx4 mice. Based on this experiment, we
found that the BL/6 variant of Rpe65 alone has no significant
effect on the cone phenotype of Rpgr mutant mice of the
BALB/c line.
In humans, it is known that cone-specific RPGR isoforms
exist.9 Similarly, strain-specific RPGR isoforms predominantly
expressed in cone photoreceptors might contribute to the
different phenotypes. To date, no such strain- or cone-specific
RPGR isoforms have been described in mice. Similarly, a strain-
specific single nucleotide polymorphism or mutation in a cone-
specific gene provides another explanation for the differences
between BL/6 and BALB/c mice. Another potentially protective
factor in BL/6 retinas might be the pigment. However, because
we did not observe a difference in the two lines regarding the
impairment of the rod system but only for cones, we consider
this explanation rather unlikely. Additional genetic analyses,
such as QTL mapping, are necessary to map and identify the
respective modifiers. Identification of such genes might help to
better understand the distinct molecular characteristics of rod
and cone photoreceptors.
Disease Course of Retinal Degeneration from
RPGR Mutations
In humans, mutations in RPGR lead to XlRP, a severe early-
onset rod degeneration, in some cases followed by cone de-
generation. To date, three different splice site mutations in
intron 4 were reported in patients with XLRP.29,47,48 All them
occurred at the splice donor site (positions1 and3) and are
supposed to lead to omission of exon 4 in the respective
transcripts. Indeed, exon skipping was demonstrated for the
mutation at position 3.29 Exon 4 is part of the coding region
of the RCC-1-like domain (RLD).5 The amino acid residues are
100% identical in human and mouse, and a significant portion
of mutations are located in the RLD. In addition, it was shown
to bind several interaction partners such as RPGRIP1,12 SMC1
and SMC3,35 and PDE6.14 Of importance, it has been shown
that missense mutations within the RLD abolished its binding
to RPGRIP1 isoforms.12
Patients with cone-dominated phenotypes and RPGR muta-
tions were also described, illustrating the clinical heterogeneity
of RPGR-related retinopathies. Two naturally occurring canine
models develop a mild late-onset or very severe early-onset
disease, depending on the mutation.49 Nevertheless, in both
models, rods were primarily affected with cones involved later.
These models thus reflect the classical pathogenesis of RP
because rod degeneration precedes cone cell death.
In addition, two Rpgr mouse lines were described. An Rpgr
knock-out mouse line exhibited mild retinal degeneration in-
volving both rods and cones. The ERG was taken at a single
time point (6.5 months); thus, no discrimination of rod and
cone photoreceptors can be made over time. Still, the cone
phenotype was more pronounced. Of note, the mouse is on a
mixed BL/6J1 background. Thus, either the lack of the RPGR
default variant leads to affection of both rod and cone photo-
receptors or the mixed genetic background has an impact on
the additional involvement of cones that was not present in our
RpgrEx4 BL/6 mice. Transgenic mice with expression of a
truncated RPGR-ORF15 protein revealed rapid photoreceptor
degeneration, in contrast to the slow degeneration in the
knockout line. ERG measurements displayed a decrease of the
scotopic a- and b- waves at approximately 1.5 months of age
(P40). Cone responses also declined; however, this effect was
not quantified. Compared with the canine and murine models,
the RpgrEx4 BALB/c line represents a model for cone-rod
degeneration. Our mouse lines expressing a transcript that
leads to a deletion of 21 amino acids in the predicted RLD can
be regarded as a model for disease-associated human mutations
(in-frame deletions and insertions as well as missense muta-
tions), leading to altered RPGR proteins in patients, which
account for approximately 48% of all mutations described
(http://rpgr.hgu.mrc.ac.uk).
Defect of Ciliary Transport but Not
Ciliary Structure
We showed that RPGR and RPGRIP1 are correctly localized in
mutants and that the ciliary structure is not obviously compro-
mised. Thus, retinal disease might rather be explained by an
altered protein function caused by different disease-associated
mutations. This is supported by the observed mislocalization of
rhodopsin and cone opsin early in disease. Mislocalization
preceded the decline in the scotopic but not the photopic ERG
amplitudes in RpgrEx4 BL/6 animals, but it occurred simulta-
neously with amplitude reduction in RpgrEx4 BALB/c. Thus,
partial mislocalization of visual pigments might not be suffi-
cient to trigger impairments in the phototransduction cascade
or signal transmission that is sensitive to ERG. Still, this mislo-
calization might render rod and cone photoreceptors more
susceptible to the influence of additional pathogenic modifying
effects. Mislocalization of visual pigments is a common pheno-
type in patients and animals with RPGR mutations and in
mouse models with mutations in proteins of ciliary transport
pathways.37,41,42,50,51 Based on these results and the findings
in our Rpgr overexpressing52 and transgenic mouse lines, we
hypothesize that quantitative or qualitative alterations of RPGR
lead to changes in the composition of a large ciliary protein
complex. Consequently, these alterations may result in func-
tional defects of ciliary transport mechanisms, leading to dis-
ease.
In conclusion, we have generated two mutant mouse lines
carrying the same in-frame mutation (RpgrEx4) on two differ-
ent genetic backgrounds. A strain-specific impact mainly on
the cone photoreceptors in the BALB/c line was observed.
Therefore, this mouse line represents the first model for a
cone-rod phenotype caused by a mutation in an RP-associated
gene. Because of its similarity to a subset in human patients,
this mouse line provides the basis for improving our under-
standing of the observed differences in clinical outcomes of
RPGR-related retinal degenerations. Furthermore, it allows fur-
ther investigation of the function of RPGR in rods and cones.
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